Genetics Opens a New Era in Prevention: Anticipating Disease Before Symptoms Appear

Preventive medicine is undergoing a profound transformation. Beyond traditional check-ups based on standardized tests, a more precise, predictive, and personalized model is emerging—one that integrates medical history, lifestyle, biomarkers, and genomic medicine. This is the approach led by the new Advanced Health Unit at Hospital Ruber Internacional, with the aim of anticipating disease and promoting healthy longevity.

"Preventive medicine has changed radically: we no longer perform the same check-ups for everyone, but rather tailor-made assessments based on each person’s medical history, lifestyle, and risk profile," explains Dr. Arántzazu Álvarez de Arcaya, specialist in Internal Medicine and one of the heads of the unit. "Today, the challenge is not to perform more tests, but to identify the right ones in order to make truly useful clinical decisions."

High resolution image. This link will open using lightbox, there may be a context switchDres. Javier Sanz y Arantza Álvarez de ArcayaThis innovative model focuses on quality and medical relevance, avoiding overdiagnosis and overtreatment. "Performing more tests does not mean practicing better medicine. The key is to identify those that provide clinical value and improve the patient’s prognosis," adds Dr. Álvarez de Arcaya.

The Advanced Health Unit structures its programs according to parameters such as age and gender, differentiating strategies based on each patient’s profile. In earlier stages of life, the main goal is to identify modifiable risk factors and prevent disease through a predictive, individualized, and proactive approach.

"It is a mistake to think that being symptom-free means being healthy. Many diseases progress silently for years," warns the specialist.

From a certain age onward, the focus broadens to include the early detection of subclinical disease, the prevention of cardiovascular events, and the preservation of physical and cognitive autonomy. "It is not only about living longer, but about living better, with quality of life and functionality for a longer time," she emphasizes.

Within this model, medical genetics plays a key role. Dr. Javier Sanz, an expert in predictive medicine and pharmacogenomics, highlights that "we have moved from an approach based on population averages to one centered on individual risk. Two people with the same clinical profile may have very different risks depending on their genetics."

Genomic medicine makes it possible to anticipate disease even years before the first symptoms appear. "Today, we can identify genetic predispositions to cardiovascular disease or cancer and act early by adjusting both monitoring and preventive interventions," explains Dr. Sanz.

In addition, pharmacogenomics opens the door to safer and more effective medicine. "It allows us to personalize treatments from the outset, avoiding adverse effects and reducing trial and error in drug selection," he states.

Both specialists agree that the future of preventive medicine lies in integrating all these elements into a more human and participatory model. "The true value of a medical check-up lies in turning data into an individualized action plan. Without a plan, we only have information; with one, we have decisions that improve health," concludes Dr. Álvarez de Arcaya.

The Advanced Health Unit is therefore committed to a paradigm shift: from the passive patient to the active patient, supported by a multidisciplinary medical team that guides them throughout their life.

"Prevention is not a one-time act, but a continuous process that requires guidance and shared goals," concludes Dr. Javier Sanz.